A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells.
about
Nuclear envelope composition determines the ability of neutrophil-type cells to passage through micron-scale constrictions.Noninvasive imaging of cell-mediated therapy for treatment of cancer.Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.
P2860
A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A self-inactivating retrovecto ...... enetically engineered T-cells.
@en
type
label
A self-inactivating retrovecto ...... enetically engineered T-cells.
@en
prefLabel
A self-inactivating retrovecto ...... enetically engineered T-cells.
@en
P2093
P2860
P356
P1433
P1476
A self-inactivating retrovecto ...... enetically engineered T-cells.
@en
P2093
Clément Couture
Diana E Jaalouk
Jacques Galipeau
Laurence Lejeune
P2860
P2888
P356
10.1186/1743-422X-3-97
P577
2006-11-21T00:00:00Z
P6179
1037413416